Neutralizing antibody responses against the Respiratory Syncytial Virus

Jul 7, 2023News&events0 comments

New paper dissecting the neutralizing antibody responses against the Respiratory Syncytial Virus; a new approach to virus neutralization assay validation and future application in clinical studies. Published on the “Journal of medical virology”

Link to full paper 

Shares

Related Articles

VisMederi and the International Vaccine Institute have formed a new partnership to accelerate vaccine development in developing countries.

VisMederi and the International Vaccine Institute have formed a new partnership to accelerate vaccine development in developing countries.

VisMederi Diagnostics opens a new collection point in Siena

VisMederi Diagnostics opens a new collection point in Siena

Simone Paletti, Chief Financial Officer, speaker at the key finance forum in Milan organized by “Comunicazione Italiana”

Simone Paletti, Chief Financial Officer, speaker at the key finance forum in Milan organized by “Comunicazione Italiana”

VisMederi Group at the World Vaccine Congress in Washington, D.C.

VisMederi Group at the World Vaccine Congress in Washington, D.C.

VisMederi has achieved a distinguished place in the prestigious FT 1000 ranking by the Financial Times

VisMederi has achieved a distinguished place in the prestigious FT 1000 ranking by the Financial Times

VisMederi at the University of Siena’s prestigious event “USiena Game”

VisMederi at the University of Siena’s prestigious event “USiena Game”

Share